Breaking News
12 Glaring Realities Of Marxist Socialism
The EU & The Iron Law Of Oligarchy
Iron Ore Below $100 As UBS Warns "Fundamentals Are Deteriorating"
Global Bond Market On Edge As Japanese Yields Soar After "Horrible" 10Y JGB Auction
Top Tech News
Voyager 1 approaches one light day from Earth
Visual Implants
Renewable Energy Breakthrough! World's Most Efficient Tesla Turbine System
I Told You So
Meet Sunbird, a nuclear fusion-powered space tug concept from Pulsar Fusion.
China and Russia launch 29-nation AI alliance to rival western control of technology
BREAKING: China has begun manufacturing domestically developed Immersion Deep...
Idaho's High Desert Becomes Hot Spot For Nuclear Power Revolution
The World's Largest Electric Aircraft Is About to Take Its First Flight
Tesla Cybercabs and Superchargers Will Act as Mini Cell Towers for SpaceX Starlink
Samumed worth $12 billion is working on tissue regeneration to combat alzheimers and more
They have a biotechnology platform based on small molecule-based Wnt pathway modulation, they develop therapeutics to address a range of degenerative diseases, regenerative medicine and oncology.
One of the primary signaling pathways that regulate the self-renewal and differentiation of adult stem cells is the Wnt pathway, which plays a crucial role in tissue health, ranging from formation to replenishment and from repair to regeneration of various tissues.
Samumed's small-molecule drug platform is harnessing the innate restorative power of the Wnt pathway to reverse the course of severe and prevalent diseases.